Nextcure Stock Investor Sentiment
| NXTC Stock | USD 0.50 0.01 1.96% |
About 62% of all NextCure's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding NextCure suggests that some traders are interested. The current market sentiment, together with NextCure's historical and current headlines, can help investors time the market. In addition, many technical investors use NextCure stock news signals to limit their universe of possible portfolio assets.
NextCure Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards NextCure can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of NextCure's Stock prices. Below is the latest headlines and news related to NextCure Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about NextCure that are available to investors today. This information is accessible both publicly - through NextCure's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of NextCure-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of NextCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NextCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NextCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NextCure alpha.
NextCure Largest EPS Surprises
Earnings surprises can significantly impact NextCure's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-03-19 | 2024-12-31 | -0.36 | -0.41 | -0.05 | 13 | ||
2021-03-04 | 2020-12-31 | -0.6 | -0.54 | 0.06 | 10 | ||
2024-11-04 | 2024-09-30 | -0.34 | -0.41 | -0.07 | 20 | ||
2022-05-05 | 2022-03-31 | -0.67 | -0.74 | -0.07 | 10 | ||
2020-03-12 | 2019-12-31 | -0.45 | -0.34 | 0.11 | 24 | ||
2024-05-02 | 2024-03-31 | -0.46 | -0.61 | -0.15 | 32 |
There is far too much social signal, news, headlines, and media speculation about NextCure that are available to investors today. This information is accessible both publicly - through NextCure's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of NextCure-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of NextCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NextCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NextCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NextCure alpha.
NextCure Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | NextCures Buy Rating Reiterated at HC Wainwright | 03/07/2025 |
2 | Acquisition by Kabakoff David S of 28050 shares of NextCure at 1.5 subject to Rule 16b-3 | 03/14/2025 |
3 | Acquisition by Jones Elaine V of 14250 shares of NextCure at 1.62 subject to Rule 16b-3 | 03/17/2025 |
4 | Acquisition by Timothy Mayer of 93900 shares of NextCure at 2.23 subject to Rule 16b-3 | 03/18/2025 |
5 | Acquisition by Morrison Briggs of 14250 shares of NextCure at 24.13 subject to Rule 16b-3 | 03/21/2025 |
6 | Acquisition by Sourav Kundu of 75000 shares of NextCure at 1.55 subject to Rule 16b-3 | 03/25/2025 |
7 | NextCure stock hits 52-week low at 0.3 amid sharp decline By Investing.com - Investing.com South Africa | 04/09/2025 |
8 | NextCure Advances LNCB74 Program in Phase 1 Study NXTC Stock News | 05/01/2025 |
Complementary Tools for NextCure Stock analysis
When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |